12,641
Views
27
CrossRef citations to date
0
Altmetric
Editorial

Candida albicans morphology: still in focus

&
Pages 327-330 | Received 10 Jan 2017, Accepted 31 Jan 2017, Published online: 21 Feb 2017

The yeast-to-hyphal transition (dimorphism) of the most common human pathogenic yeast Candida albicans remains in the focus of molecular and medical mycology [Citation1Citation4]. Since our review on ‘C. albicans dimorphisms as a therapeutic target’ in 2012 [Citation5], over 100 studies and reviews focusing on the morphology of this yeast have been published, dealing with the multiple aspects of this crucial virulence attribute.

The studies include diverse topics such as large-scale functional screening studies [Citation6Citation8], interaction with bacteria and their products, interaction with other fungi, new regulatory factors, the role of the vacuole and trafficking, hyphal-associated genes and their functions, hyphal tip and directed growth, hyphal extension and branching, the role of hyphal formation during interaction with macrophages, and finally, large-scale compound screening to identify inhibitors and characterization of selected inhibitors.

As one of the new emerging topics, clinically relevant interactions of C. albicans with bacteria were investigated by several groups with fungal morphology as a crucial element. In most studies, bacteria were found to inhibit fungal filamentation, often by secreted compounds that are linked to bacterial quorum sensing, virulence factors, or metabolism [Citation9Citation12]. In the case of Fusobacterium nucleatum, however, hyphal inhibition was contact dependent [Citation13]. Interestingly, both probiotic and facultative pathogenic bacteria were shown to negatively affect hyphal formation [Citation9,Citation10,Citation12Citation15]. It, therefore, appears possible that the interaction with bacteria, rather than distinct environmental conditions or transcriptional programs, is responsible for the predominance of C. albicans yeast morphology in the gastrointestinal tract. Depletion of bacteria by antibiotics might alleviate bacteria-induced suppression of filamentation and thereby contribute to the shift of C. albicans from a commensal to pathogen. This would be a significant new finding as it may explain at least in part what triggers the shift to pathogenicity.

Not all Candida–bacterial interactions are antagonistic; synergistic interactions have been described, for example, for streptococci [Citation16], favoring mixed biofilm formation, and Staphylococcus aureus. For S. aureus, the role of C. albicans hyphal formation in the interaction appears to be niche specific: While filamentation is dispensable for enhanced virulence in peritoneal coinfection [Citation17], S. aureus uses attachment to C. albicans hyphae to invade across mucosal barriers and to cause systemic infections [Citation18]. Similarly, it has been shown that C. albicans hyphae can pave the way for another pathogenic nonfilamentous Candida species, C. glabrata [Citation19]. However, it should be noted that C. glabrata can be highly pathogenic for man, even without a coinfection with C. albicans [Citation20].

Although the regulation of the morphological transition is already well investigated [Citation1Citation4,Citation21], multiple new regulatory factors directly or indirectly involved in hyphal formation and new insights into regulatory mechanisms have been reported.

For example, it has been shown that activation of Ras1, a key regulator of morphogenesis, requires proteolysis, mitochondrial activity, and the adenylate cyclase Cyr1 [Citation22,Citation23]. Furthermore, signaling for hyphal formation is associated with cell cycle-independent phospho-regulation of Fkh2 [Citation24] and mediated by septins [Citation25]. A genetic approach to dissect hyphal development identified a novel function for the transcription factor Ace2 [Citation26], and diminished expression of the protein kinase Cak1 was shown to bypass filamentation [Citation27]. A similar subtle level of regulation was shown when Hog1 basal activity was reduced [Citation28]. A further link in the complex regulatory network was the identification of a novel feedback circuit formed by the known regulators Brg1 and Nrg1 form [Citation29]. In addition, ceramide synthases [Citation30] and regulation of actin organization [Citation31] play important roles during filamentous growth. A novel link between phenotypic switching and yeast-to-hyphal transition was also found by demonstrating that white and opaque cells undergo distinct programs of filamentous growth [Citation32]. These studies nicely complete our understanding of the already complex picture of the regulation of dimorphism.

Three further subtopics in regulation of hyphal development were in the highlights: (1) the role of oxygen concentrations, (2) the role of the mediator complex, and (3) quorum sensing. Clearly, in vivo hyphal formation is mediated by a mix of environmental signals in the host, which includes hypoxia, temperature, CO2 concentrations, and nutrient conditions, which in turn require a complex network of signaling factors and modules [Citation33,Citation34]. An interesting connection between filament regulation and the general transcription machinery has been found by the discovery that the mediator complex is directly linked to transcriptional regulation of hyphal regulators and hypha-associated genes [Citation35Citation37]. Farnesol is the dominant quorum-sensing molecule and acts via different pathways. Novel discoveries of its mode of action include inhibition of Cup9 degradation, which in turn leads to repressed expression of SOK1, encoding a kinase required for degradation of Nrg1 to facilitate initiation of hyphal growth [Citation38]. Farnesol-mediated cell death was found to depend on Efg1 and Cph1, thereby possibly explaining the lower resistance of opaque cells to farnesol [Citation39]. A new discovery was that farnesol affects not only hyphal initiation but also hypha-to-yeast transition [Citation40], which might partially explain the hyphal maintenance defect of an EED1 deletion mutant. This mutant is the first identified to be hypersensitive to farnesol, via unknown mechanisms distinct from pathways known to be targeted by farnesol, and at the same time produces increased amounts of this molecule [Citation41]. After over a decade of intensive research on farnesol, many open questions remain regarding the existence of receptors and transporters and regulation of its synthesis, recently summarized in a commentary by Nickerson and Atkins [Citation42]. Finally, recent evidence demonstrates that it negatively affects the host immune response [Citation43,Citation44], thereby reducing its suitability for therapeutic approaches.

In contrast to the well-characterized hyphal initiation, the mechanisms of hyphal extension are poorly understood but are in the focus of more recent studies [Citation1]. One of the critical factors for hyphal extension is Eed1, a regulator of Ume6. As mentioned above, Eed1 controls farnesol sensitivity, and farnesol resistance might contribute to hyphal maintenance [Citation41]. The molecular mechanisms behind this are still elusive. An interesting finding was that phosphorylation of Exo84 by Cdk1–Hgc1 is necessary for efficient hyphal extension [Citation45]. As part of the exocyst, this complex is essential for cell surface expansion. In Saccharomyces cerevisiae, phosphorylation of Exo84 leads to exocyst disassembly, demonstrating redirection of conserved pathways in C. albicans to facilitate hyphal maintenance. Clearly, the maintenance of hyphal extension is as important as the initiation of hyphal formation and should be further investigated in detail. Similarly, we still know very little about the hyphal-to-yeast transition, which is equally crucial for pathogenicity and commensal growth.

Critical for the pathogenic potential of hyphae is also the directed growth and extension at the hyphal tip. This requires, among others, the protein Cdc42 [Citation46,Citation47]. The dynamics of this GTPase and the local activity [Citation48] control directional growth and promote thigmotropism, which contributes to invasion. Hyphal tip growth requires intracellular compartments, vesicles, and trafficking. For example, it has been shown that prevacuolar compartment RabGTPases impact hyphal growth [Citation49]; that the protein Sec2p is physically associated with SEC2 mRNA on secretory vesicles [Citation45]; and that vacuolar acidification is essential for morphology and virulence [Citation50]. One new, but related, aspect of hyphal growth and pathogenicity is hyphal branching, which precise role still remains to be elucidated [Citation51,Citation52].

Of note, the virulence potential of hyphae is not mediated by the hyphal morphology per se, but by genes which expression is associated with the morphological program. For example, the hyphal wall protein 1 (Hwp1) is required for virulence in distinct niches [Citation53] and Csa2, a member of the Rbt5 protein family, is involved in the utilization of iron from hemoglobin during hyphal growth [Citation54]. However, one study showed that hyphal growth does not always require induction of hyphal-specific genes [Citation55], and another study found that the core filamentation response network is restricted to only eight genes [Citation56].

One of these genes, ECE1, was already discovered in the 1990s due to its high expression during hypha formation. However, its function remained unknown until last year [Citation57]. In fact, Ece1 is a polyprotein consisting of eight short peptides, each separated by lysine–arginine residues. The polyprotein is sequentially processed at these dibasic amino acids by two serine proteases, resulting in peptide secretion. One of these peptides adopts an α-helical structure and permeabilizes host epithelial membranes causing cell lysis and was therefore named Candidalysin. Deletion of the Candidalysin-encoding region from the ECE1 gene abolished the ability of C. albicans to damage epithelial cells and significantly attenuated virulence. Therefore, the production of Candidalysin rather than hyphal formation per se is the mediator of host (epithelial) cell damage. These observations provide the elusive link between hyphal formation and host (epithelial) cell damage and explain why C. albicans filaments are the pathogenic morphology during mucosal infections.

Hyphal formation also plays a key role during interaction of C. albicans with macrophages. Here, significant progress has been made in elucidating some vital questions: How does C. albicans inhibit phagosome acidification? Which intracellular mechanisms cause hyphal formation? How is hyphal formation linked to host cell death? One study showed that hyphal formation and masking of β-glucan via mannan inhibit macrophage phagosome maturation and thus acidification [Citation58]. However, active alkalinization of the phagosome seems to be the main mechanism, which triggers intracellular hyphal formation. This modulation of phagosomal pH requires Stp2p [Citation59], a regulator of amino acid transport, and members of the ATO gene family for transport of ammonia into the phagosome, which in turn causes neutralization of the phagosomal pH [Citation60]. Although it has long been thought that physical piercing of the macrophage membrane by hyphae is the only cause of macrophage cell death, two studies have shown that killing by intracellular C. albicans cells is a two-step mechanism. In fact, C. albicans triggers pyroptosis, an inflammasome-associated programmed cell death, before physical forces cause membrane rupture [Citation61]. The associated interleukin-1β production, however, seems to be independent of hyphal formation [Citation62]. The significance of intracellular hyphal formation within macrophages was also highlighted by a microevolution experiment, where the nonfilamentous C. albicans efg1∆/cph1∆ mutant was exposed to macrophages for several months [Citation37]. Intriguingly, a single point mutation within a gene (SSN3) encoding a component of the Cdk8 module of the mediator complex, which links transcription factors with the general transcription machinery (see above), was sufficient to bypass Efg1/Cph1-dependent filamentation.

Finally, as predicted in our previous review, multiple new compounds have been identified in the last years, some based on large-scale compound screening [Citation63Citation65], which inhibit hyphal formation and, as shown in some studies, the corresponding hyphal-associated properties and virulence. This included filastatin [Citation66], ascorbic acid [Citation66], mucins [Citation67], gymnemic acids [Citation68], and quinacrine [Citation69] to name only a few. Of note, even known antifungals seem to have specific effects on the different morphological forms of C. albicans, and one azole was shown to force the fungus into the yeast growth mode, potentially due to reduced ergosterol content of the cell membrane [Citation70]. In agreement with that information, one study identified ergosterol synthesis as a critical aspect in a large-scale functional screening to identify regulators of morphogenesis [Citation7].

In summary, hyphal formation and maintenance remain an area of intensive research with exciting discoveries to be made that are both relevant for our understanding of fungal biology and with a great potential to lead to novel adjunctive therapies.

Declaration of interest

The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Additional information

Funding

The authors were supported by the Deutsche Forschungsgemeinschaft (TR/CRC FungiNet to IDJ, and BH; SPP1580 DFG 528/16 and DFG 528/17 to BH; and DFG JA 1960/1-1 to IDJ), the Infect ERA-NET Program (FunComPath; BMBF031L0001A) to BH; the Integrated Research and Treatment Center for Sepsis Control and Care (CSCC) to IDJ and BH; the Jena School for Microbial Communication (JSMC), and the International Leibniz Research School (ILRS) to BH and IJ.

References

  • Lu Y, Su C, Liu H. Candida albicans hyphal initiation and elongation. Trends Microbiol. 2014;22(12):707–714.
  • Noble SM, Gianetti BA, Witchley JN. Candida albicans cell-type switching and functional plasticity in the mammalian host. Nat Rev Microbiol. 2016;15:96–108.
  • Rizzetto L, Weil T, Cavalieri D. Systems level dissection of Candida recognition by dectins: a matter of fungal morphology and site of infection. Pathogens. 2015;4(3):639–661.
  • Yang W, Yan L, Wu C, et al. Fungal invasion of epithelial cells. Microbiol Res. 2014;169(11):803–810.
  • Jacobsen ID, Wilson D, Wächtler B, et al. Candida albicans dimorphism as a therapeutic target. Expert Rev Anti Infect Ther. 2012;10(1):85–93.
  • Carlisle PL, Kadosh D. A genome-wide transcriptional analysis of morphology determination in Candida albicans. Mol Biol Cell. 2013;24(3):246–260.
  • O’Meara TR, Veri AO, Ketela T, et al. Global analysis of fungal morphology exposes mechanisms of host cell escape. Nat Commun. 2015;6:6741.
  • Ryan O, Shapiro RS, Kurat CF, et al. Global gene deletion analysis exploring yeast filamentous growth. Science. 2012;337(6100):1353–1356.
  • Cruz MR, Graham CE, Gagliano BC, et al. Enterococcus faecalis inhibits hyphal morphogenesis and virulence of Candida albicans. Infect Immun. 2013;81(1):189–200.
  • Matsubara VH, Wang Y, Bandara HM, et al. Probiotic lactobacilli inhibit early stages of Candida albicans biofilm development by reducing their growth, cell adhesion, and filamentation. Appl Microbiol Biotechnol. 2016;100(14):6415–6426.
  • Morales DK, Grahl N, Okegbe C, et al. Control of Candida albicans metabolism and biofilm formation by Pseudomonas aeruginosa phenazines. MBio. 2013;4(1):e00526–00512.
  • van Leeuwen PT, van der Peet JM, Bikker FJ, et al. Interspecies interactions between Clostridium difficile and Candida albicans. Msphere. 2016;1:6.
  • Bor B, Cen L, Agnello M, et al. Morphological and physiological changes induced by contact-dependent interaction between Candida albicans and Fusobacterium nucleatum. Sci Rep. 2016;6:27956.
  • Bandara HM, Cheung BP, Watt RM, et al. Secretory products of Escherichia coli biofilm modulate Candida biofilm formation and hyphal development. J Investig Clin Dent. 2013;4(3):186–199.
  • Orsi CF, Sabia C, Ardizzoni A, et al. Inhibitory effects of different lactobacilli on Candida albicans hyphal formation and biofilm development. J Biol Regul Homeost Agents. 2014;28(4):743–752.
  • Falsetta ML, Klein MI, Colonne PM, et al. Symbiotic relationship between Streptococcus mutans and Candida albicans synergizes virulence of plaque biofilms in vivo. Infect Immun. 2014;82(5):1968–1981.
  • Nash EE, Peters BM, Palmer GE, et al. Morphogenesis is not required for Candida albicans-Staphylococcus aureus intra-abdominal infection-mediated dissemination and lethal sepsis. Infect Immun. 2014;82(8):3426–3435.
  • Schlecht LM, Peters BM, Krom BP, et al. Systemic Staphylococcus aureus infection mediated by Candida albicans hyphal invasion of mucosal tissue. Microbiology. 2015;161(Pt 1):168–181.
  • Tati S, Davidow P, McCall A, et al. Candida glabrata binding to Candida albicans hyphae enables its development in oropharyngeal Candidiasis. Plos Pathog. 2016;12(3):e1005522.
  • Brunke S, Hube B. Two unlike cousins: Candida albicans and C. glabrata infection strategies. Cell Microbiol. 2013;15(5):701–708.
  • Wang Y. Hgc1-Cdc28-how much does a single protein kinase do in the regulation of hyphal development in Candida albicans? J Microbiol. 2016;54(3):170–177.
  • Grahl N, Demers EG, Lindsay AK, et al. Mitochondrial activity and Cyr1 are key regulators of Ras1 activation of C. albicans virulence pathways. Plos Pathog. 2015;11(8):e1005133.
  • Piispanen AE, Grahl N, Hollomon JM, et al. Regulated proteolysis of Candida albicans Ras1 is involved in morphogenesis and quorum sensing regulation. Mol Microbiol. 2013;89(1):166–178.
  • Greig JA, Sudbery IM, Richardson JP, et al. Cell cycle-independent phospho-regulation of Fkh2 during hyphal growth regulates Candida albicans pathogenesis. Plos Pathog. 2015;11(1):e1004630.
  • Blankenship JR, Cheng S, Woolford CA, et al. Mutational analysis of essential septins reveals a role for septin-mediated signaling in filamentation. Eukaryot Cell. 2014;13(11):1403–1410.
  • Calderon-Norena DM, Gonzalez-Novo A, Orellana-Munoz S, et al. A single nucleotide polymorphism uncovers a novel function for the transcription factor Ace2 during Candida albicans hyphal development. Plos Genet. 2015;11(4):e1005152.
  • Woolford CA, Lagree K, Xu W, et al. Bypass of Candida albicans filamentation/biofilm regulators through diminished expression of protein kinase Cak1. Plos Genet. 2016;12(12):e1006487.
  • Su C, Lu Y, Liu H. Reduced TOR signaling sustains hyphal development in Candida albicans by lowering Hog1 basal activity. Mol Biol Cell. 2013;24(3):385–397.
  • Cleary IA, Lazzell AL, Monteagudo C, et al. BRG1 and NRG1 form a novel feedback circuit regulating Candida albicans hypha formation and virulence. Mol Microbiol. 2012;85(3):557–573.
  • Cheon SA, Bal J, Song Y, et al. Distinct roles of two ceramide synthases, CaLag1p and CaLac1p, in the morphogenesis of Candida albicans. Mol Microbiol. 2012;83(4):728–745.
  • Douglas LM, Wang HX, Konopka JB. The MARVEL domain protein Nce102 regulates actin organization and invasive growth of Candida albicans. MBio. 2013;4(6):e00723–00713.
  • Si H, Hernday AD, Hirakawa MP, et al. Candida albicans white and opaque cells undergo distinct programs of filamentous growth. Plos Pathog. 2013;9(3):e1003210.
  • Desai PR, van Wijlick L, Kurtz D, et al. Hypoxia and temperature regulated morphogenesis in Candida albicans. Plos Genet. 2015;11(8):e1005447.
  • Lu Y, Su C, Solis NV, et al. Synergistic regulation of hyphal elongation by hypoxia, CO(2), and nutrient conditions controls the virulence of Candida albicans. Cell Host Microbe. 2013;14(5):499–509.
  • Haran J, Boyle H, Hokamp K, et al. Telomeric ORFs (TLOs) in Candida spp. encode mediator subunits that regulate distinct virulence traits. Plos Genet. 2014;10(10):e1004658.
  • Tebbji F, Chen Y, Richard Albert J, et al. A functional portrait of Med7 and the mediator complex in Candida albicans. Plos Genet. 2014;10(11):e1004770.
  • Wartenberg A, Linde J, Martin R, et al. Microevolution of Candida albicans in macrophages restores filamentation in a nonfilamentous mutant. Plos Genet. 2014;10(12):e1004824.
  • Lu Y, Su C, Unoje O, et al. Quorum sensing controls hyphal initiation in Candida albicans through Ubr1-mediated protein degradation. Proc Natl Acad Sci U S A. 2014;111(5):1975–1980.
  • Langford ML, Hargarten JC, Patefield KD, et al. Candida albicans Czf1 and Efg1 coordinate the response to farnesol during quorum sensing, white-opaque thermal dimorphism, and cell death. Eukaryot Cell. 2013;12(9):1281–1292.
  • Lindsay AK, Deveau A, Piispanen AE, et al. Farnesol and cyclic AMP signaling effects on the hypha-to-yeast transition in Candida albicans. Eukaryot Cell. 2012;11(10):1219–1225.
  • Polke M, Sprenger M, Scherlach K, et al. A functional link between hyphal maintenance and quorum sensing in Candida albicans. Mol Microbiol. 2016 Sep 14. doi: 10.1111/mmi.13526. [Epub ahead of print].
  • Nickerson KW, Atkin AL. Deciphering fungal dimorphism: farnesol’s unanswered questions. Mol Microbiol. 2016 Dec 17. doi: 10.1111/mmi.13601. [Epub ahead of print].
  • Hargarten JC, Moore TC, Petro TM, et al. Candida albicans quorum sensing molecules stimulate mouse macrophage migration. Infect Immun. 2015;83(10):3857–3864.
  • Leonhardt I, Spielberg S, Weber M, et al. The fungal quorum-sensing molecule farnesol activates innate immune cells but suppresses cellular adaptive immunity. MBio. 2015;6(2):e00143.
  • Caballero-Lima D, Sudbery PE. In Candida albicans, phosphorylation of Exo84 by Cdk1-Hgc1 is necessary for efficient hyphal extension. Mol Biol Cell. 2014;25(7):1097–1110.
  • Brand AC, Morrison E, Milne S, et al. Cdc42 GTPase dynamics control directional growth responses. Proc Natl Acad Sci U S A. 2014;111(2):811–816.
  • Thomson DD, Wehmeier S, Byfield FJ, et al. Contact-induced apical asymmetry drives the thigmotropic responses of Candida albicans hyphae. Cell Microbiol. 2015;17(3):342–354.
  • Pulver R, Heisel T, Gonia S, et al. Rsr1 focuses Cdc42 activity at hyphal tips and promotes maintenance of hyphal development in Candida albicans. Eukaryot Cell. 2013;12(4):482–495.
  • Johnston DA, Tapia AL, Eberle KE, et al. Three prevacuolar compartment Rab GTPases impact Candida albicans hyphal growth. Eukaryot Cell. 2013;12(7):1039–1050.
  • Patenaude C, Zhang Y, Cormack B, et al. Essential role for vacuolar acidification in Candida albicans virulence. J Biol Chem. 2013;288(36):26256–26264.
  • Mech F, Wilson D, Lehnert T, et al. Epithelial invasion outcompetes hypha development during Candida albicans infection as revealed by an image-based systems biology approach. Cytometry A. 2014;85(2):126–139.
  • Wilson D, Mayer FL, Miramon P, et al. Distinct roles of Candida albicans-specific genes in host-pathogen interactions. Eukaryot Cell. 2014;13(8):977–989.
  • Staab JF, Datta K, Rhee P. Niche-specific requirement for hyphal wall protein 1 in virulence of Candida albicans. PLoS One. 2013;8(11):e80842.
  • Okamoto-Shibayama K, Kikuchi Y, Kokubu E, et al. Csa2, a member of the Rbt5 protein family, is involved in the utilization of iron from human hemoglobin during Candida albicans hyphal growth. FEMS Yeast Res. 2014;14(4):674–677.
  • Naseem S, Araya E, Konopka JB. Hyphal growth in Candida albicans does not require induction of hyphal-specific gene expression. Mol Biol Cell. 2015;26(6):1174–1187.
  • Martin R, Albrecht-Eckardt D, Brunke S, et al. A core filamentation response network in Candida albicans is restricted to eight genes. PLoS One. 2013;8(3):e58613.
  • Moyes DL, Wilson D, Richardson JP, et al. Candidalysin is a fungal peptide toxin critical for mucosal infection. Nature. 2016;532(7597):64–68.
  • Bain JM, Louw J, Lewis LE, et al. Candida albicans hypha formation and mannan masking of beta-glucan inhibit macrophage phagosome maturation. MBio. 2014;5(6):e01874.
  • Vylkova S, Lorenz MC. Modulation of phagosomal pH by Candida albicans promotes hyphal morphogenesis and requires Stp2p, a regulator of amino acid transport. Plos Pathog. 2014;10(3):e1003995.
  • Danhof HA, Lorenz MC. The Candida albicans ATO gene family promotes neutralization of the macrophage phagolysosome. Infect Immun. 2015;83(11):4416–4426.
  • Uwamahoro N, Verma-Gaur J, Shen HH, et al. The pathogen Candida albicans hijacks pyroptosis for escape from macrophages. MBio. 2014;5(2):e00003–00014.
  • Wellington M, Koselny K, Krysan DJ. Candida albicans morphogenesis is not required for macrophage interleukin 1beta production. MBio. 2012;4(1):e00433–00412.
  • Fazly A, Jain C, Dehner AC, et al. Chemical screening identifies filastatin, a small molecule inhibitor of Candida albicans adhesion, morphogenesis, and pathogenesis. Proc Natl Acad Sci U S A. 2013;110(33):13594–13599.
  • Heintz-Buschart A, Eickhoff H, Hohn E, et al. Identification of inhibitors of yeast-to-hyphae transition in Candida albicans by a reporter screening assay. J Biotechnol. 2013;164(1):137–142.
  • Stylianou M, Uvell H, Lopes JP, et al. Novel high-throughput screening method for identification of fungal dimorphism blockers. J Biomol Screen. 2015;20(2):285–291.
  • van Hauwenhuyse F, Fiori A, van Dijck P. Ascorbic acid inhibition of Candida albicans Hsp90-mediated morphogenesis occurs via the transcriptional regulator Upc2. Eukaryot Cell. 2014;13(10):1278–1289.
  • Kavanaugh NL, Zhang AQ, Nobile CJ, et al. Mucins suppress virulence traits of Candida albicans. MBio. 2014;5(6):e01911.
  • Vediyappan G, Dumontet V, Pelissier F, et al. Gymnemic acids inhibit hyphal growth and virulence in Candida albicans. PLoS One. 2013;8(9):e74189.
  • Kulkarny VV, Chavez-Dozal A, Rane HS, et al. Quinacrine inhibits Candida albicans growth and filamentation at neutral pH. Antimicrob Agents Chemother. 2014;58(12):7501–7509.
  • Kasper L, Miramon P, Jablonowski N, et al. Antifungal activity of clotrimazole against Candida albicans depends on carbon sources, growth phase and morphology. J Med Microbiol. 2015;64(7):714–723.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.